Impact of genetic variability in the ABCG2 gene on ABCG2 expression, function, and interaction with AT1 receptor antagonist telmisartan

Biochemical and Biophysical Research Communications

Volumn 443, Issue 4, 2014, Pages 1211-1217

  Deppe, Sylvia ^a   Ripperger, Anne ^b   Weiss, Johanna ^c   Ergün, Süleyman ^d   Benndorf, Ralf A ^b  

^a TECHNICAL UNIVERSITY OF BRAUNSCHWEIG   (Germany)

^b MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^c UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^d UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

ABCG2; AT1 receptor antagonists; ATP binding cassette (ABC) transporter; Polymorphism; Telmisartan

Indexed keywords

ABCG2; AT1 RECEPTOR ANTAGONISTS; ATP-BINDING CASSETTE (ABC) TRANSPORTER; POLYMORPHISM; TELMISARTAN;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ARGININE; ATP-BINDING CASSETTE TRANSPORTERS; BENZIMIDAZOLES; BENZOATES; BINDING SITES; CHLOROPHYLL; GENETIC VARIATION; HEK293 CELLS; HUMANS; MUTAGENESIS, SITE-DIRECTED; MUTATION; NEOPLASM PROTEINS; POLYMORPHISM, GENETIC; RECOMBINANT PROTEINS;

EID: 84893815881     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.12.119     Document Type: Article

References (24)

1. B. Sarkadi, L. Homolya, G. Szakács, and A. Váradi Human multidrug resistance ABCB and ABCG transporters: participation in a chemoimmunity defense system Physiol. Rev. 86 2006 1179 1236 (Pubitemid 44521651)
2. O. Zolk, and M.F. Fromm Transporter-mediated drug uptake and efflux: important determinants of adverse drug reaction Clin. Pharmacol. Ther. 89 2011 798 805
3. E.M. Leslie, R.G. Deeley, and S.P. Cole Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense Toxicol. Appl. Pharmacol. 204 2005 216 237 (Pubitemid 40552845)
4. Z. Ni, and Q. Mao ATP-binding cassette efflux transporters in human placenta Curr. Pharm. Biotechnol. 12 2011 674 685
5. R. Allikmets, L.M. Schriml, A. Hutchinson, V. Romano-Spica, and M. Dean A human placenta-specific ATP-binding cassette gene (ABCP) on chromosome 4q22 that is involved in multidrug resistance Cancer Res. 58 1998 5337 5339 (Pubitemid 28551112)
6. A.E. Stacy, P.J. Jansson, and D.R. Richardson Molecular pharmacology of ABCG2 and its role in chemoresistance Mol. Pharmacol. 84 2013 655 669
7. O.M. Woodward, A. Köttgen, J. Coresh, E. Boerwinkle, W.B. Guggino, and M. Köttgen Identification of a urate transporter, ABCG2, with a common functional polymorphism causing gout Proc. Natl. Acad. Sci. U.S.A. 106 2013 10338 10342
8. L. Erdem, E. Giovannetti, L.G. Leon, R. Honeywell, and G.J. Peters Polymorphisms to predict outcome to the tyrosine kinase inhibitors gefitinib, erlotinib, sorafenib and sunitinib Curr. Top. Med. Chem. 12 2012 1649 1659
9. I. Ieiri Functional significance of genetic polymorphisms in P-glycoprotein (MDR1, ABCB1) and breast cancer resistance protein (BCRP, ABCG2) Drug Metab. Pharmacokinet. 27 2012 85 105
10. S. Deppe, R.H. Böger, J. Weiss, and R.A. Benndorf Telmisartan: a review of its pharmacodynamic and pharmacokinetic properties Expert Opin. Drug. Metab. Toxicol. 6 2010 863 871
11. J. Weiss, A. Sauer, N. Divac, M. Herzog, E. Schwedhelm, R.H. Böger, W.E. Haefeli, and R.A. Benndorf Interaction of angiotensin receptor type 1 blockers with ATP-binding cassette transporters Biopharm. Drug Dispos. 31 2010 150 161
12. J. Weiss, A. Sauer, M. Herzog, R.H. Böger, W.E. Haefeli, and R.A. Benndorf Interaction of thiazolidinediones (glitazones) with the ATP-binding cassette transporters P-glycoprotein and breast cancer resistance protein Pharmacology 84 2009 264 270
13. R.A. Benndorf, E. Schwedhelm, A. Gnann, R. Taheri, G. Kom, M. Didié, A. Steenpass, S. Ergün, and R.H. Böger Isoprostanes inhibit vascular endothelial growth factor-induced endothelial cell migration, tube formation, and cardiac vessel sprouting in vitro, as well as angiogenesis in vivo via activation of the thromboxane A(2) receptor: a potential link between oxidative stress and impaired angiogenesis Circ. Res. 103 2008 1037 1046
14. R.A. Benndorf, C. Krebs, B. Hirsch-Hoffmann, E. Schwedhelm, G. Cieslar, R. Schmidt-Haupt, O.M. Steinmetz, C. Meyer-Schwesinger, F. Thaiss, M. Haddad, S. Fehr, A. Heilmann, U. Helmchen, L. Hein, H. Ehmke, R.A. Stahl, R.H. Böger, and U.O. Wenzel Angiotensin II type 2 receptor deficiency aggravates renal injury and reduces survival in chronic kidney disease in mice Kidney Int. 75 2009 1039 1049
15. D. Biermann, A. Heilmann, M. Didié, S. Schlossarek, A. Wahab, M. Grimm, M. Römer, H. Reichenspurner, K.R. Sultan, A. Steenpass, S. Ergün, S. Donzelli, L. Carrier, H. Ehmke, W.H. Zimmermann, L. Hein, R.H. Böger, and R.A. Benndorf Impact of AT2 receptor deficiency on postnatal cardiovascular development PLoS ONE 7 2012 e47916
16. M. Schupp, J. Janke, R. Clasen, T. Unger, and U. Kintscher Angiotensin type 1 receptor blockers induce peroxisome proliferator-activated receptor-gamma activity Circulation 109 2004 2054 2057 (Pubitemid 38620211)
17. R.A. Benndorf, T. Rudolph, D. Appel, E. Schwedhelm, R. Maas, F. Schulze, E. Silberhorn, and R.H. Böger Telmisartan improves insulin sensitivity in nondiabetic patients with essential hypertension Metabolism 55 2006 1159 1164 (Pubitemid 44219053)
18. M. Bajcetic, R.A. Benndorf, D. Appel, E. Schwedhelm, F. Schulze, D. Riekhof, R. Maas, and R.H. Böger Pharmacokinetics of oral doses of telmisartan and nisoldipine, given alone and in combination, in patients with essential hypertension J. Clin. Pharmacol. 47 2007 295 304 (Pubitemid 46294712)
19. A. Tamura, M. Watanabe, H. Saito, H. Nakagawa, T. Kamachi, I. Okura, and T. Ishikawa Functional validation of the genetic polymorphisms of human ATP-binding cassette (ABC) transporter ABCG2: identification of alleles that are defective in porphyrin transport Mol. Pharmacol. 70 2006 287 296
20. H. Sarankó, H. Tordai, Á. Telbisz, C. Özvegy-Laczka, G. Erdos, B. Sarkadi, and T. Hegedus Effects of the gout-causing Q141K polymorphism and a CFTR ΔF508 mimicking mutation on the processing and stability of the ABCG2 protein Biochem. Biophys. Res. Commun. 437 2013 140 145
21. A. Dehghan, A. Köttgen, Q. Yang, S.J. Hwang, W.L. Kao, F. Rivadeneira, E. Boerwinkle, D. Levy, A. Hofman, B.C. Astor, E.J. Benjamin, C.M. van Duijn, J.C. Witteman, J. Coresh, and C.S. Fox Association of three genetic loci with uric acid concentration and risk of gout: a genome-wide association study Lancet 372 2008 1953 1961
22. S. Koshiba, R. An, H. Saito, T. Wakabayashi, A. Tamura, and T. Ishikawa Human ABC transporters ABCG2 (BCRP) and ABCG4 Xenobiotica 38 2008 863 888
23. S. Yoshioka, K. Katayama, C. Okawa, S. Takahashi, S. Tsukahara, J. Mitsuhashi, and Y. Sugimoto The identification of two germ-line mutations in the human breast cancer resistance protein gene that result in the expression of a low/non-functional protein Pharm. Res. 24 2007 1108 1117 (Pubitemid 46798890)
24. Z.S. Chen, R.W. Robey, M.G. Belinsky, I. Shchaveleva, X.Q. Ren, Y. Sugimoto, D.D. Ross, S.E. Bates, and G.D. Kruh Transport of methotrexate, methotrexate polyglutamates, and 17beta-estradiol 17-(beta-D-glucuronide) by ABCG2: effects of acquired mutations at R482 on methotrexate transport Cancer Res. 63 2003 4048 4054 (Pubitemid 36917926)